Low dose computed tomography for the screening of lung cancer in adults

Institute of Health Economics
Record ID 32015000781
English
Authors' recommendations: In a constrained health care system, other services will need to be contracted or eliminated to free the approximately $105.68 million (annual screening) in resources needed to fund its adoption for the first five years alone. Determining whether the $105.68 million is worth the investment depends on the opportunity cost of its adoption. That is, if decision-makers were to adopt lung cancer screening with LDCT, it is imperative that they consider carefully what services would be contracted or eliminated in order to fund its adoption, and assess their associated costs and health impacts compared to lung cancer screening with LDCT.
Details
Project Status: Completed
Year Published: 2014
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: Canada
MeSH Terms
  • Humans
  • Tomography, X-Ray Computed
  • Lung Neoplasms
  • Adult
  • Diagnostic Techniques and Procedures
Contact
Organisation Name: Institute of Health Economics
Contact Address: 1200, 10405 – Jasper Avenue, Edmonton, AB T5J 3N4, Canada. Tel: +1 780 448 4881 Fax: +1 780 448 0018
Contact Name: info@ihe.ca
Contact Email: info@ihe.ca
Copyright: Institute of Health Economics (IHE)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.